Marijuana Addiction Treatment: What Works, According to Research (2026)

By James Buddsey · Updated October 14, 2026

The best-supported treatment for marijuana addiction is talk therapy, especially cognitive behavioral therapy (CBT) combined with motivational enhancement therapy (MET), often with rewards for negative drug tests (contingency management). No medication is FDA approved for cannabis use disorder yet, though several, including cannabinoid-based ones, are being studied.

Cannabis use disorder is common and mostly untreated. In a national survey of more than 36,000 U.S. adults, only 13.2% of people who had ever had the disorder had received professional treatment or joined a 12-step group. Many people assume there is nothing to treat, or that they should be able to quit on willpower. The research says otherwise: structured help improves the odds. This guide covers what treatment involves, what the evidence shows, and where to find help in Washington, Oregon and nationally.

Evidence at a Glance

Do You Need Treatment?

Cannabis use disorder is diagnosed when someone has at least two of 11 signs in a year, such as using more than intended, failed attempts to cut down, cravings, giving up activities, or using despite problems. The CDC lists the full DSM-5 criteria, and our guide to marijuana addiction explains them in detail. If you have tried to cut back and could not, that alone is a good reason to talk to a professional.

Behavioral Therapies: What Works

Psychological treatment is the backbone of care. NIDA states that cognitive behavioral therapy, motivational enhancement therapy and contingency management can be effective for cannabis use disorder. The strongest summary of the evidence is a Cochrane systematic review of 23 randomized trials with 4,045 participants.

Cognitive behavioral therapy (CBT)

CBT teaches practical skills: spotting the situations, moods and people that trigger use, handling cravings, refusing offers, and building routines that do not revolve around cannabis. It usually runs weekly for several weeks to a few months.

Motivational enhancement therapy (MET)

MET is shorter and focuses on the person’s own reasons for change. A therapist gives personal feedback on use and helps resolve mixed feelings about quitting, without lecturing. It is often delivered in a handful of sessions and combined with CBT.

Contingency management

This approach gives tangible rewards, often vouchers, for verified drug-free urine tests. The Cochrane review found that five of six studies supported adding voucher incentives to therapy.

What the results look like

Compared with minimal treatment, people who received therapy used cannabis on fewer days and had fewer dependence symptoms at about four months. The most consistently supported package was more than four sessions over more than a month, combining MET and CBT with abstinence-based incentives. Results are honest rather than miraculous: about one-quarter of participants were abstinent at final follow-up, which the reviewers note is comparable to treatment for other substances, and no single therapy was consistently better at nine months or later. Many people need more than one attempt, and reducing use is itself a meaningful gain. In one trial analysis, cutting back on cannabis was linked to improvements in anxiety, depression and sleep.

Medications Under Study

There are no FDA-approved medications for cannabis use disorder or for medically assisted withdrawal. A 2025 Cochrane review of 37 randomized trials with 3,201 participants concluded that every drug tested should still be considered experimental. Doctors may still prescribe medicines off label for symptoms like insomnia or anxiety. Here is where the main candidates stand:

• THC-based “agonist” medicines: the idea mirrors nicotine patches. In an Australian trial of 128 people, those given nabiximols, a THC and CBD mouth spray, plus counseling used illicit cannabis on about 18 fewer days over 12 weeks than those on placebo. Pooled data, however, show no clear increase in full abstinence.
• Cannabidiol (CBD): a small 2020 trial found that 400 mg and 800 mg daily doses reduced cannabis use compared with placebo. Cochrane rates the evidence on abstinence as low certainty. Store-bought CBD products are not the same as the purified doses tested.
• Gabapentin: a 50-person pilot trial reported less cannabis use and fewer withdrawal symptoms, but larger confirmation is lacking, and the 2025 Cochrane review found anticonvulsants were more likely to be stopped because of side effects.
• N-acetylcysteine: did not improve abstinence over placebo in adult trials, according to Cochrane.

Managing Withdrawal

Withdrawal is one reason people relapse early. It happens because the brain adapts to regular THC, as our explainer on how THC acts on the brain describes. A meta-analysis found 47% of regular or dependent users experience cannabis withdrawal syndrome. Expect irritability, anxiety, poor sleep, vivid dreams, low appetite and restlessness. The National Cancer Institute notes symptoms are milder than opioid or benzodiazepine withdrawal and usually fade after a few days. Practical steps that help:

• Pick a quit date and remove cannabis and gear from your home
• Plan for sleep: regular hours, no screens late, limited caffeine
• Exercise, which helps with restlessness and mood
• Tell someone you trust, and line up support for the first two weeks
• Ask a doctor about short-term help for sleep or anxiety

Medical detox is rarely needed for cannabis alone, but people who also depend on alcohol, benzodiazepines or opioids should get medical supervision.

Can Cannabis Treat Other Addictions?

This page once featured a small 2003 report by a California physician suggesting cannabis could replace alcohol for problem drinkers. That idea still circulates, but the evidence has not caught up. The National Academies’ 2017 review found no or insufficient evidence that cannabinoids help people achieve abstinence from addictive substances. Anyone treating alcohol or opioid use disorder should use proven treatments, including FDA-approved medications for those conditions, and discuss any cannabis use with their care team.

Risks and Side Effects of Continuing Use

Untreated cannabis use disorder is linked with problems in memory, attention and learning, a higher risk of psychosis among frequent users, cannabinoid hyperemesis syndrome, and impaired driving. People with the disorder also have higher rates of depression, anxiety and other substance use disorders, which a 2021 review notes often complicate treatment. Good programs treat both at once. Our reviews of marijuana and IQ and marijuana and brain damage cover the cognitive research.

Where to Get Help

• Talk to your doctor: a primary care provider can screen you, rule out other conditions and refer you to counseling.
• SAMHSA National Helpline: 1-800-662-4357, free, confidential and open 24/7, or search FindTreatment.gov for licensed programs near you.
• Washington Recovery Help Line: 1-866-789-1511, 24/7, run by Crisis Connections.
• Peer support: Marijuana Anonymous runs free 12-step meetings in person and online.
• Crisis: call or text 988 for a mental health or substance use crisis.

Marijuana Addiction Treatment FAQ

For more on how cannabis affects health, browse our Cannabis Health & Research section.

For adults 21+ in legal states. General information, not medical advice. Talk to a doctor before using cannabis for a health condition.